vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $39.6M, roughly 1.5× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -12.5%, a 48.4% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $16.1M). Over the past eight quarters, CBAK Energy Technology, Inc.'s revenue compounded faster (-0.0% CAGR vs -15.0%).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
CBAT vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $39.6M |
| Net Profit | $-7.4M | $14.2M |
| Gross Margin | 7.3% | 73.1% |
| Operating Margin | -13.6% | 32.5% |
| Net Margin | -12.5% | 35.9% |
| Revenue YoY | 131.8% | -10.9% |
| Net Profit YoY | -63.6% | 117.2% |
| EPS (diluted) | $-0.08 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $39.6M | ||
| Q3 25 | $60.9M | $43.4M | ||
| Q2 25 | $40.5M | $43.4M | ||
| Q1 25 | $34.9M | $47.3M | ||
| Q4 24 | $25.4M | $44.4M | ||
| Q3 24 | $44.6M | $53.1M | ||
| Q2 24 | $47.8M | $53.1M | ||
| Q1 24 | $58.8M | $54.8M |
| Q4 25 | $-7.4M | $14.2M | ||
| Q3 25 | $2.7M | $12.8M | ||
| Q2 25 | $-3.1M | $2.5M | ||
| Q1 25 | $-1.6M | $21.5M | ||
| Q4 24 | $-4.5M | $6.5M | ||
| Q3 24 | $17.6K | $2.8M | ||
| Q2 24 | $6.4M | $18.5M | ||
| Q1 24 | $9.8M | $18.8M |
| Q4 25 | 7.3% | 73.1% | ||
| Q3 25 | 8.0% | 70.6% | ||
| Q2 25 | 11.0% | 69.2% | ||
| Q1 25 | 13.7% | 79.7% | ||
| Q4 24 | 13.1% | 76.3% | ||
| Q3 24 | 15.6% | 81.5% | ||
| Q2 24 | 26.6% | 74.2% | ||
| Q1 24 | 31.9% | 72.1% |
| Q4 25 | -13.6% | 32.5% | ||
| Q3 25 | -6.6% | 36.6% | ||
| Q2 25 | -8.7% | 33.6% | ||
| Q1 25 | -8.2% | 51.1% | ||
| Q4 24 | -26.0% | 10.6% | ||
| Q3 24 | -1.9% | 26.1% | ||
| Q2 24 | 12.4% | 51.4% | ||
| Q1 24 | 17.4% | 44.6% |
| Q4 25 | -12.5% | 35.9% | ||
| Q3 25 | 4.4% | 29.6% | ||
| Q2 25 | -7.6% | 5.7% | ||
| Q1 25 | -4.5% | 45.4% | ||
| Q4 24 | -17.8% | 14.7% | ||
| Q3 24 | 0.0% | 5.3% | ||
| Q2 24 | 13.5% | 34.8% | ||
| Q1 24 | 16.7% | 34.2% |
| Q4 25 | $-0.08 | $0.15 | ||
| Q3 25 | $0.03 | $0.12 | ||
| Q2 25 | $-0.03 | $0.02 | ||
| Q1 25 | $-0.02 | $0.21 | ||
| Q4 24 | $-0.05 | $0.05 | ||
| Q3 24 | $0.00 | $0.03 | ||
| Q2 24 | $0.07 | $0.20 | ||
| Q1 24 | $0.11 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $164.1M |
| Total DebtLower is stronger | $4.1M | $42.8M |
| Stockholders' EquityBook value | $112.7M | $248.3M |
| Total Assets | $426.2M | $380.4M |
| Debt / EquityLower = less leverage | 0.04× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $164.1M | ||
| Q3 25 | $10.5M | $127.4M | ||
| Q2 25 | $45.7M | $152.7M | ||
| Q1 25 | $9.6M | $132.1M | ||
| Q4 24 | $11.0M | $125.0M | ||
| Q3 24 | $24.2M | $137.4M | ||
| Q2 24 | $44.1M | — | ||
| Q1 24 | $23.8M | — |
| Q4 25 | $4.1M | $42.8M | ||
| Q3 25 | $4.8M | $21.1M | ||
| Q2 25 | $4.9M | $7.1M | ||
| Q1 25 | $4.1M | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $112.7M | $248.3M | ||
| Q3 25 | $121.4M | $248.0M | ||
| Q2 25 | $118.2M | $244.6M | ||
| Q1 25 | $120.8M | $226.4M | ||
| Q4 24 | $121.7M | $195.1M | ||
| Q3 24 | $131.2M | $205.0M | ||
| Q2 24 | $126.6M | $8.8M | ||
| Q1 24 | $120.9M | $9.0M |
| Q4 25 | $426.2M | $380.4M | ||
| Q3 25 | $363.9M | $321.4M | ||
| Q2 25 | $333.1M | $315.3M | ||
| Q1 25 | $311.5M | $284.6M | ||
| Q4 24 | $302.2M | $266.1M | ||
| Q3 24 | $293.5M | $296.5M | ||
| Q2 24 | $279.6M | $19.5M | ||
| Q1 24 | $286.5M | $19.8M |
| Q4 25 | 0.04× | 0.17× | ||
| Q3 25 | 0.04× | 0.09× | ||
| Q2 25 | 0.04× | 0.03× | ||
| Q1 25 | 0.03× | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $52.0M |
| Free Cash FlowOCF − Capex | $16.1M | $51.2M |
| FCF MarginFCF / Revenue | 27.3% | 129.3% |
| Capex IntensityCapex / Revenue | 23.4% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $52.0M | ||
| Q3 25 | $14.6M | $-20.9M | ||
| Q2 25 | $13.8M | $-8.3M | ||
| Q1 25 | $-9.6M | $1.9M | ||
| Q4 24 | $9.6M | $-7.3M | ||
| Q3 24 | $19.7M | $5.0M | ||
| Q2 24 | $2.9M | $19.2M | ||
| Q1 24 | $7.4M | $3.7M |
| Q4 25 | $16.1M | $51.2M | ||
| Q3 25 | $6.0M | $-20.9M | ||
| Q2 25 | $4.1M | $-8.6M | ||
| Q1 25 | $-22.3M | $1.7M | ||
| Q4 24 | $3.9M | $-7.9M | ||
| Q3 24 | $16.5M | $4.6M | ||
| Q2 24 | $2.5M | $18.3M | ||
| Q1 24 | $-454.0K | $3.0M |
| Q4 25 | 27.3% | 129.3% | ||
| Q3 25 | 9.9% | -48.3% | ||
| Q2 25 | 10.2% | -19.9% | ||
| Q1 25 | -63.9% | 3.5% | ||
| Q4 24 | 15.5% | -17.8% | ||
| Q3 24 | 37.1% | 8.7% | ||
| Q2 24 | 5.2% | 34.5% | ||
| Q1 24 | -0.8% | 5.4% |
| Q4 25 | 23.4% | 2.0% | ||
| Q3 25 | 14.1% | 0.1% | ||
| Q2 25 | 23.8% | 0.7% | ||
| Q1 25 | 36.3% | 0.5% | ||
| Q4 24 | 22.5% | 1.3% | ||
| Q3 24 | 7.0% | 0.8% | ||
| Q2 24 | 0.9% | 1.6% | ||
| Q1 24 | 13.4% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | 5.51× | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 1115.72× | 1.77× | ||
| Q2 24 | 0.46× | 1.04× | ||
| Q1 24 | 0.76× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
